MARKET

EDSA

EDSA

Edesa Biotech Inc
NASDAQ
5.33
-0.49
-8.42%
Pre Market: 5.36 +0.03 +0.56% 05:10 03/31 EDT
OPEN
5.61
PREV CLOSE
5.82
HIGH
5.74
LOW
5.06
VOLUME
147
TURNOVER
0
52 WEEK HIGH
9.37
52 WEEK LOW
0.7200
MARKET CAP
44.50M
P/E (TTM)
-4.6481
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at EDSA last week (0323-0327)?
Weekly Report · 1d ago
Edesa Biotech Confirms Mid-2026 Start for Phase 2 Vitiligo Trial of EB06
TipRanks · 4d ago
Edesa Biotech provides update on EB06 clinical study
TipRanks · 4d ago
Edesa Biotech Reaffirms Enrollment Timeline Guidance For Phase 2 Clinical Study Of EB06 In Moderate-To-Severe Nonsegmental Vitiligo
Benzinga · 4d ago
Edesa Biotech advances EB06 Phase 2 vitiligo study; enrollment begins mid-2026
Reuters · 4d ago
Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment
Barchart · 5d ago
Weekly Report: what happened at EDSA last week (0316-0320)?
Weekly Report · 03/23 09:10
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 03/17 17:05
More
About EDSA
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company developing ways to treat inflammatory and immune-related diseases. The Company’s clinical pipeline is focused on two therapeutic areas: medical dermatology and respiratory. In medical dermatology, the Company is developing EB06, an anti-CXCL10 monoclonal antibody candidate, as a therapy for vitiligo, a common autoimmune disorder that causes skin to lose its color in patches. Its medical dermatology assets also include EB01 (1.0% daniluromer cream), a Phase III-ready asset developed for use as a potential therapy for moderate-to-severe chronic allergic contact dermatitis (ACD), a common occupational skin condition. The Company’s advanced respiratory drug candidate is EB05 (paridiprubart), which is being evaluated in a United States government-funded platform study as a treatment for acute respiratory distress syndrome.

Webull offers Edesa Biotech Inc stock information, including NASDAQ: EDSA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EDSA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EDSA stock methods without spending real money on the virtual paper trading platform.